Non-Video (Fibre) Ureteroscopes Market Growth Outlook to 2035 Driven by Emerging Healthcare Infrastructure – News and Statistics

Abstract

According to the latest IndexBox report on the global Non-Video (Fibre) Ureteroscopes market, the market enters 2026 with broader demand fundamentals, more disciplined procurement behavior, and a more regionally diversified supply architecture.

The global market for non-video (fibre) ureteroscopes remains a resilient niche within urological endoscopy, anchored by the enduring clinical utility of fibre-optic image transmission in settings where cost, durability, and disposability are paramount. Despite the accelerating shift toward digital video ureteroscopes in high-volume, well-funded hospitals, fibre-based systems continue to command a meaningful share of procedural volumes, particularly in outpatient clinics, emerging-market hospitals, and pediatric urology departments. This report provides a data-driven analysis of the market from the 2026 base year through 2035, covering product types (flexible, semi-rigid, reusable, single-use, digital fibre, and pediatric models), clinical applications (urolithiasis, stricture diagnosis, tumor biopsy, stent placement, diagnostic and therapeutic ureteroscopy), and value chain stages (optical fibre manufacturing, alloy production, sterilization, distribution, and clinical use). The market is shaped by a dual-speed dynamic: in advanced economies, fibre scopes serve as backup or secondary devices, while in cost-sensitive regions they remain the primary tool for ureterorenoscopy. This geographic and economic bifurcation creates distinct growth trajectories. The forecast horizon to 2035 incorporates baseline assumptions of moderate digital substitution, stable reimbursement for fibre-based procedures in public health systems, and incremental material science improvements in fibre-optic bundles. Key demand-side indicators include global urolithiasis incidence, surgical volume growth in low- and middle-income countries, and hospital budget constraints that sustain demand for lower-cost capital equipment. The analysis systematically evaluates supply chain constraints, trade flow

The baseline scenario for the non-video (fibre) ureteroscopes market from 2026 to 2035 assumes a continuation of current trends: moderate global volume growth driven by rising urolithiasis prevalence, expanding surgical access in emerging economies, and persistent demand for low-cost, durable endoscopic tools in resource-constrained settings. The market is projected to grow at a compound annual growth rate (CAGR) of approximately 2.8% from 2025 to 2035, with the market index reaching 132 by 2035 (2025=100). This growth is supported by several structural factors. First, the global burden of kidney stone disease continues to rise, with incidence increasing in both developed and developing regions due to dietary changes, obesity, and climate-related dehydration. Second, healthcare infrastructure expansion in Asia-Pacific, Latin America, and parts of Africa is driving procurement of cost-effective urological equipment, where fibre ureteroscopes offer a favorable price-performance ratio compared to digital alternatives. Third, the reusable fibre scope segment benefits from established reprocessing workflows and lower per-procedure costs in high-volume centers. Fourth, single-use fibre ureteroscopes are gaining traction in settings where cross-contamination risk or reprocessing logistics are challenging, such as ambulatory surgery centers and emergency departments. Fifth, pediatric urology remains a dedicated niche where smaller-diameter fibre scopes are preferred due to limited availability of pediatric digital models. However, the baseline scenario also incorporates headwinds: continued substitution by digital video ureteroscopes in premium hospital segments, price erosion in mature markets, and regulatory pressures on reprocessing standards that may increase operating cost

Demand Drivers and Constraints

Primary Demand Drivers

• Rising global incidence of urolithiasis due to dietary and lifestyle factors
• Expanding healthcare infrastructure and surgical capacity in emerging economies
• Cost advantage of fibre ureteroscopes over digital video systems in budget-constrained settings
• Growing adoption of single-use fibre scopes to reduce cross-contamination and reprocessing costs
• Sustained demand in pediatric urology where smaller-diameter fibre scopes are preferred
• Reimbursement policies in public health systems that favor lower-cost capital equipment

Potential Growth Constraints

• Accelerating substitution by digital video ureteroscopes with superior image quality and functionality
• Price erosion in mature markets due to competitive pressure and procurement consolidation
• Regulatory tightening on reprocessing standards for reusable devices, raising operational costs
• Limited innovation in fibre-optic technology compared to digital imaging advancements
• Supply chain vulnerabilities in optical fibre and medical-grade alloy manufacturing

Demand Structure by End-Use Industry

Hospitals (Public and Private) (estimated share: 45%)

Hospitals represent the largest end-use segment for non-video fibre ureteroscopes, driven by high procedural volumes in urology departments. In public hospitals across emerging economies, fibre scopes remain the primary tool for ureterorenoscopy due to budget constraints and established procurement channels. In private hospitals in developed markets, fibre scopes are increasingly relegated to backup roles or specific procedures where digital scopes are unavailable or impractical. The demand story is shaped by hospital procurement cycles, which typically favor reusable devices with long lifespans. Key demand-side indicators include hospital bed density, surgical volume growth, and government health expenditure. Through 2035, hospital demand will grow in Asia-Pacific and Latin America, while in North America and Europe, volume growth will be modest as digital substitution accelerates. The segment is supported by the need for cost-effective solutions in high-volume stone treatment centers. Current trend: Stable to slight decline in high-income countries; growth in emerging markets.

Major trends: Shift toward centralized procurement and group purchasing organizations, Increasing adoption of single-use fibre scopes in ambulatory surgery centers, Integration of fibre scopes with existing reprocessing infrastructure, and Growing preference for flexible fibre scopes over semi-rigid in hospital settings.

Representative participants: Karl Storz, Olympus, Richard Wolf, Stryker, and Boston Scientific.

Ambulatory Surgery Centers (ASCs) (estimated share: 20%)

Ambulatory surgery centers are an expanding channel for ureteroscopic procedures, particularly in the United States and Western Europe, where outpatient surgery is incentivized by payers. ASCs prioritize operational efficiency and low capital expenditure, making single-use fibre ureteroscopes an attractive option. The demand story centers on the trade-off between per-procedure cost and reprocessing logistics: ASCs often lack the volume or infrastructure to justify reusable scope reprocessing, so disposable fibre models reduce cross-contamination risk and eliminate capital outlay. Key indicators include the number of ASCs, procedure volume growth, and reimbursement rates for outpatient ureteroscopy. Through 2035, ASC demand for fibre scopes is expected to grow faster than the hospital segment, driven by the expansion of outpatient urology services and the introduction of new single-use fibre products. The trend is supported by regulatory shifts favoring outpatient care and by manufacturer efforts to lower the cost of disposable scopes. Current trend: Growing, driven by single-use fibre scope adoption.

Major trends: Rapid adoption of single-use fibre ureteroscopes in ASCs, Increased procedure volume for stone removal and diagnostic ureteroscopy, Preference for flexible fibre scopes with improved tip deflection, and Partnerships between ASC chains and device manufacturers for volume-based pricing.

Representative participants: Boston Scientific, Cook Medical, BD, Neoscope Inc, and Coloplast.

Urology Clinics and Specialty Centers (estimated share: 18%)

Urology clinics and specialty centers represent a significant but slowly declining share of fibre ureteroscope demand, as higher-end clinics in developed markets transition to digital systems. However, in cost-sensitive markets and for specific procedures (e.g., diagnostic ureteroscopy, stent placement), fibre scopes remain the workhorse. The demand story is driven by the need for reliable, low-maintenance equipment in settings with limited technical support. Key indicators include the number of urology clinics per capita, average procedure fees, and equipment replacement cycles. Through 2035, demand in this segment will be sustained by clinics in emerging economies and by the availability of refurbished or lower-cost fibre scopes. The trend is also influenced by the growing role of tele-urology and remote diagnostics, where fibre scopes with standard light sources are compatible with existing infrastructure. Current trend: Stable, with gradual shift to digital in high-end clinics.

Major trends: Gradual digital substitution in high-revenue clinics, Sustained demand for fibre scopes in diagnostic and follow-up procedures, Increased use of paediatric fibre scopes in specialty pediatric urology clinics, and Adoption of hybrid systems combining fibre optics with external camera heads.

Representative participants: Olympus, Karl Storz, Richard Wolf, Maxer Endoscopy, and Vimex Endoscopy.

Academic and Research Institutions (estimated share: 10%)

Academic medical centers and research institutions use fibre ureteroscopes primarily for training, skills development, and clinical research. Fibre scopes are preferred in simulation labs due to their lower cost and durability compared to digital models. The demand story is linked to the number of urology residency programs, surgical training volumes, and research grants focused on endoscopic techniques. Key indicators include the number of urology trainees, simulation lab budgets, and publication trends in endourology. Through 2035, demand in this segment will remain stable, with periodic replacement cycles. The segment also supports innovation through collaborations with manufacturers to test new fibre-optic materials or scope designs. The trend is reinforced by the need for cost-effective training tools in low-resource settings, where academic institutions often serve as regional training hubs. Current trend: Stable, with focus on training and innovation.

Major trends: Integration of fibre scopes into simulation-based training curricula, Research on fibre-optic image enhancement and durability, Use of fibre scopes in comparative effectiveness studies vs. digital scopes, and Collaboration between academic centers and manufacturers for product development.

Representative participants: Karl Storz, Olympus, Stryker, Boston Scientific, and Cook Medical.

Government and Military Medical Facilities (estimated share: 7%)

Government hospitals and military medical facilities represent a stable, procurement-driven segment for fibre ureteroscopes. These institutions prioritize ruggedness, low total cost of ownership, and compatibility with existing sterilization infrastructure. Fibre scopes are often specified in tenders due to their proven reliability and lower upfront cost. The demand story is shaped by defense health budgets, public hospital procurement cycles, and international aid programs that supply urological equipment to low-income countries. Key indicators include government health expenditure, military medical readiness programs, and multilateral procurement volumes. Through 2035, demand will be steady, with occasional spikes linked to large-scale procurement contracts. The segment is less sensitive to digital substitution due to longer replacement cycles and standardized procurement specifications. The trend is supported by the need for field-deployable, lightweight endoscopic equipment in military settings. Current trend: Steady, with procurement driven by cost and durability.

Major trends: Long-term procurement contracts with standardized specifications, Preference for reusable fibre scopes with proven durability, Integration of fibre scopes into mobile surgical units and field hospitals, and Procurement through international health organizations and development banks.

Representative participants: Karl Storz, Olympus, Richard Wolf, BD, and Vimex Endoscopy.

Key Market Participants

Regional Dynamics

Asia-Pacific (estimated share: 38%)

Asia-Pacific dominates the non-video fibre ureteroscope market, driven by high urolithiasis prevalence, expanding hospital networks in China and India, and cost sensitivity. The region will account for the largest volume growth through 2035, supported by rising surgical volumes and government investments in urological care. Direction: growing.

North America (estimated share: 28%)

North America remains a significant market, but fibre scopes face strong substitution by digital video systems in hospitals. Demand is sustained in ASCs and for single-use fibre models. The market is mature, with growth limited to procedural volume increases and replacement cycles. Direction: stable to slight decline.

Europe (estimated share: 20%)

Europe shows stable demand, with fibre scopes used in public hospitals and clinics where budget constraints limit digital adoption. Western Europe sees gradual decline, while Eastern Europe and Turkey offer moderate growth. Reimbursement policies and reprocessing regulations shape procurement. Direction: stable.

Latin America (estimated share: 8%)

Latin America is a growth market, driven by expanding healthcare access in Brazil and Mexico. Fibre scopes are preferred for their lower cost. Demand is supported by rising urolithiasis incidence and public health programs. Infrastructure challenges and economic volatility temper growth. Direction: growing.

Middle East & Africa (estimated share: 6%)

Middle East and Africa represent a small but growing market, with demand concentrated in Gulf Cooperation Council countries and South Africa. Fibre scopes are used in public hospitals and aid programs. Growth is constrained by limited surgical capacity but supported by medical tourism and infrastructure investments. Direction: growing.

Market Outlook (2026-2035)

In the baseline scenario, IndexBox estimates a 2.8% compound annual growth rate for the global non-video (fibre) ureteroscopes market over 2026-2035, bringing the market index to roughly 132 by 2035 (2025=100).

Note: indexed curves are used to compare medium-term scenario trajectories when full absolute volumes are not publicly disclosed.

For full methodological details and benchmark tables, see the latest IndexBox Non-Video (Fibre) Ureteroscopes market report.